Beiersdorf stock weighs NIVEA turnaround against Derma momentum
Published on 11/02/2026 at 14:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points for investors
- NIVEA remains in an 18-month turnaround phase as Beiersdorf works to rebalance its core skin-care business.
- Derma momentum provides an important counterweight to weaker performance in the flagship brand.
- The next company communication focuses on the January-to-September 2026 quarterly statement.
Beiersdorf's investor-relations calendar keeps the company's January-to-September 2026 quarterly statement at the center of attention after the group moved into a new phase of its NIVEA recovery plan. The company says the webcast was scheduled for October 27, while its investor-relations page highlights an 18-month turnaround plan for NIVEA and continued strength in Derma.
The business mix is important for investors. NIVEA remains the flagship skin-care brand, so a recovery in its performance would have a broader effect on Consumer results than gains in smaller growth areas. Derma momentum offers support, but it does not remove the need for progress in the core brand.
Market focus shifts to execution
Beiersdorf stock traded at 83.40 euros on Lang & Schwarz at 14:00 CET on Monday, November 2, 2026, 0.72 percent above the Xetra close of Friday, October 30. The reference close was 82.80 euros. The move gives the stock a fresh market-based publication angle without changing the operational question: whether the NIVEA rebalancing can improve the group's growth profile.
Investors can follow the real-time quote of Beiersdorf stock as trading develops. The next key signal is the company's quarterly communication and the detail it provides on brand momentum, margins and the turnaround timetable.
Beiersdorf stock facts
- Company: Beiersdorf AG
- ISIN: DE0005200000
- Ticker: BEI.DE
- Lang & Schwarz quote: 83.40 euros, Monday, November 2, 2026, 14:00 CET
- Change versus Xetra close: 0.72 percent above 82.80 euros
- Xetra close: Friday, October 30, 2026
Germany's DAX provides the relevant broader-market backdrop for the stock; see current DAX market reports.
For the company calendar and financial materials, Beiersdorf's investor-relations page lists the quarterly statement and the NIVEA rebalancing strategy. More news and analyses on Beiersdorf stock are available in the company topic overview.
